Trastuzumab Suspended Phase N/A Trials for Cancer, Breast

IndicationsStatusPurposePhase
SuspendedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02062983Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients